National Institutes of Health
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health. Its application deadline is not stated in the source record.
We could not verify this deadline.
This listing carries no application deadline we can confirm, so it may no longer be open. Check the official solicitation before investing time, and create a free account to see opportunities we can verify are live.
Overview
PAR-25-297: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) March 31, 2025This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission. Department of Health and Human…